SOURCE: Burrill & Company

Burrill & Company

February 04, 2013 08:45 ET

Burrill Securities Continues Expansion of Its Investment Banking Activities With Addition of Andrew Daniels

SAN FRANCISCO, CA--(Marketwire - Feb 4, 2013) - Burrill Securities, a division of Burrill & Company, today announced that Andrew Daniels, a veteran of Deutsche Bank Securities and Cowen and Company, has joined Burrill Securities as Managing Director in the Equity Capital Markets Group. Andrew brings tremendous expertise to the group's capital raising efforts.

The addition of Daniels, who joins the firm from Merriman Capital, follows the hiring of Frederick Frank as Chairman of Burrill Securities and Mary Tanner as Senior Managing Director earlier this year. Daniels brings to Burrill deep experience raising capital for life sciences companies through CMPOs, PIPEs, registered direct offerings, and other instruments. Daniels' past work has included engagements with companies such as Cougar, Medivation, Kosan, Micromet, and Genelabs.

"We are committed to helping our industry's leading life sciences companies succeed. Whether through global partnering, strategic M&A, or raising capital through our global network of quality investors," says Stephen Hurly, CEO of Burrill Securities. "Andrew's addition further strengthens our team as we build out our investment banking operations to help our clients access the capital they need to fuel their growth."

Daniels brings almost 20 years of investment banking experience and has been exclusively focused on life sciences companies since 1999. Prior to Merriman Capital, he held the position with Janney Securities, Deutsche Bank Securities, Cowen and Company, and Paramount Capital. He began his career at Morgan Stanley.

He earned an MBA from Columbia Business School, and a BBA from The University of Michigan, Ann Arbor.

About Burrill Securities LLC
Burrill Securities provides life sciences companies with access to financial resources through global capital and a complementary blend of financial advisory services on public and private financings and cross-border transactions, including M&A, strategic partnerships, spinouts, and public and private capital raising. It provides companies enhanced access to public market investors through its Institutional Equities business. Our team has extensive experience and a comprehensive global network to help life sciences companies access capital and strategic partners to build their businesses. Burrill Securities LLC, member FINRA/SIPC is the investment banking arm of Burrill & Company.

About Burrill & Company
Founded in 1994, Burrill & Company is a diversified global financial services firm focused on the life sciences industry. With $1.5 billion in assets under management, the firm's businesses include venture capital/private equity, merchant banking, and media. By leveraging the scientific and business networks of its team, Burrill & Company has established unrivaled access and visibility in the life sciences industry. This unique combination of resources and capabilities enables the company to provide life sciences companies with capital, transactional support, management expertise, insight, market intelligence, and analysis through its investments, conferences, and publications. Headquartered in San Francisco, the company oversees a global network of offices throughout the United States, Latin America, Europe, and Asia. For more information visit: www.burrillandco.com.

Contact Information

  • Contact:
    Daniel Levine
    Managing Director
    Burrill & Company
    Email Contact
    415-591-5449